Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
565-02-007 ISMRM Abstract

MRI-Based Habitat Imaging for Differentiating Primary Central Nervous System Lymphoma and Atypical High-Grade Glioma

Primary: Neuro - Tumors
Secondary: Analysis Methods - Classification and Prediction
565-02-007 · Neuro-Oncology and Ear, Nose, and Throat Cancer · Wednesday, 13 May, 9:15 AM–10:10 AM · Digital Posters Row F
Keywords: Habitat Primary Central Nervous System Lymphoma High-Grade Glioma CE-T2 FLAIR
Accepted
Yu Zhang 1, Han Bao1, Junjie Ye2, Jiyuan Yang1, Yang Lei1, Junyi Li1, Jia Xie1, Yang Song3, Meining Chen3, Chengxiu Zhang4, Wei Sheng3, Zongfang Li1
1The First Affiliated Hospital of Kunming Medical University, Kunming, China
2Yunnan Institute of Population and Family Planning Science and Technology, KUNMING, China
3MR Research Collaboration Team, Shanghai, China
4Shanghai Key Laboratory of Magnetic Resonance, Shanghai, China
Presenting Author: Yu Zhang

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Villanueva G, Guscott M, Schaiquevich P, Sampor C, Combs R, Tentoni N, et al. A systematic review of high-dose methotrexate for adults with primary central nervous system lymphoma. Cancers (Basel). 2023;15(5):1459. doi:10.3390/cancers15051459. [doi]
2. Schaff LR, Mellinghoff IK. Glioblastoma and other primary brain malignancies in adults: a review. JAMA. 2023;329(7):574–587. doi:10.1001/jama.2023.0023. [doi]
3. [3] Han Y, Wang ZJ, Li WH, Yang Y, Zhang J, Yang XB, et al. Differentiation between primary central nervous system lymphoma and atypical glioblastoma based on MRI morphological feature and signal intensity ratio: a retrospective multicenter study. Front Oncol. 2022;12:811197. doi:10.3389/fonc.2022.811197. [doi]
4. Li S, Dai Y, Chen J, Yan F, Yang Y. MRI-based habitat imaging in cancer treatment: current technology, applications, and challenges. Cancer Imaging. 2024;24(1):107. doi:10.1186/s40644-024-00758-9. [doi]
5. Lee EK, Lee EJ, Kim S, Lee YS. Importance of contrast-enhanced fluid-attenuated inversion recovery magnetic resonance imaging in various intracranial pathologic conditions. Korean J Radiol. 2016 Jan–Feb;17(1):127–141. doi:10.3348/kjr.2016.17.1.127. [doi]
6. [6] Jin T, Zhang H, Liu X, Kong X, Makamure J, Chen Z, et al. Enhancement degree of brain metastases: correlation analysis between enhanced T2 FLAIR and vascular permeability parameters of dynamic contrast-enhanced MRI. Eur Radiol. 2021;31(8):5595–5604. doi:10.1007/s00330-020-07625-8. [doi]
7. Lee YC, Suh S, Ryoo I, Jung H, Joo L. Imaging finding and analysis of brain lymphoma in contrast-enhanced fluid attenuated inversion recovery sequence. Eur J Radiol. 2022 Oct;155:110490. doi:10.1016/j.ejrad.2022.110490. [doi]
8. Ellingson BM, Bendszus M, Boxerman JL, Barboriak D, Erickson BJ, Smits M, et al. Consensus recommendations for a standardized brain tumor imaging protocol in clinical trials. Neuro Oncol. 2015 Sep;17(9):1188–1198. doi:10.1093/neuonc/nov095. [doi]
9. Verma R, Correa R, Hill VB, Statsevych V, Bera K, Beig N, et al. Tumor habitat-derived radiomic features at pretreatment MRI that are prognostic for progression-free survival in glioblastoma are associated with key morphologic attributes at histopathologic examination: a feasibility study. Radiol Artif Intell. 2020 Nov 11;2(6):e190168. doi:10.1148/ryai.2020190168. [doi]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/565-02-007